Beta Interferon - Global Market Trajectory & Analytics

Global Beta Interferon Market to Reach $3.7 Billion by 2027

Amid the COVID-19 crisis, the global market for Beta Interferon estimated at US$3.1 Billion in the year 2020, is projected to reach a revised size of US$3.7 Billion by 2027, growing at a CAGR of 2.6% over the period 2020-2027.

The U.S. Market is Estimated at $846.4 Million, While China is Forecast to Grow at 4.1% CAGR

The Beta Interferon market in the U.S. is estimated at US$846.4 Million in the year 2020. China, the world`s second largest economy, is forecast to reach a projected market size of US$706.5 Million by the year 2027 trailing a CAGR of 4.1% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 1.7% and 2.2% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 2% CAGR.

Select Competitors (Total 42 Featured):

• Amoytop Biotech
• Anke Bio
• Changchun Institute of Biological Products
• Hainan Unipul Pharmaceutical
• Kawin
• Kexing Biopharm
• Merck
• Roche
• Sinopharm
• SP (Brinny) Company
• Tri-Prime Gene